PMID- 32885935
OWN - NLM
STAT- MEDLINE
DCOM- 20210503
LR  - 20210503
IS  - 1122-0643 (Print)
IS  - 1122-0643 (Linking)
VI  - 90
IP  - 3
DP  - 2020 Aug 7
TI  - ROS1 positive non-small cell lung cancer with pulmonary embolism in a 22-year 
      woman.
LID - 10.4081/monaldi.2020.1435 [doi]
AB  - ROS1-rearrangement occurs in 1-2% of non-small cell lung cancer (NSCLC). This 
      mutation is predominantly seen in relatively young, non-smoker, female with 
      adenocarcinoma. Association of pulmonary embolism with ROS1-rearranged NSCLC has 
      been suggested. We report a case of a 22-year-old woman with ROS1-positive NSCLC 
      and pulmonary embolism. This case possibly represents the youngest patient in the 
      literature.
FAU - Datta, Ananda
AU  - Datta A
AD  - Department of Pulmonary Medicine and Critical Care, All India Institute of 
      Medical Sciences, Bhubaneswar. 19.ananda.88@gmail.com.
FAU - Mantha, Satya Padmaja
AU  - Mantha SP
AD  - Department of Pulmonary Medicine and Critical Care, All India Institute of 
      Medical Sciences, Bhubaneswar. padmaja.satya@gmail.com.
FAU - Mitra, Suvradeep
AU  - Mitra S
AD  - Department of Pathology, All India Institute of Medical Sciences, Bhubaneswar. 
      sugreebm@gmail.com.
FAU - Mohapatra, Prasanta
AU  - Mohapatra P
AD  - Department of Pulmonary Medicine and Critical Care, All India Institute of 
      Medical Sciences, Bhubaneswar. prmohapatra@hotmail.com.
FAU - Goud, M Srikanth
AU  - Goud MS
AD  - Department of Pulmonary Medicine and Critical Care, All India Institute of 
      Medical Sciences, Bhubaneswar. goudsri76@gmail.com.
FAU - Panigrahi, Manoj Kumar
AU  - Panigrahi MK
AD  - Department of Pulmonary Medicine and Critical Care, All India Institute of 
      Medical Sciences, Bhubaneswar. pulmed_manoj@aiimsbhubaneswar.edu.in.
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20200807
PL  - Italy
TA  - Monaldi Arch Chest Dis
JT  - Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
JID - 9307314
RN  - 0 (Anticoagulants)
RN  - 0 (Proto-Oncogene Proteins)
RN  - EC 2.7.10.1 (Protein-Tyrosine Kinases)
RN  - EC 2.7.10.1 (ROS1 protein, human)
SB  - IM
MH  - Adenocarcinoma of Lung/classification/diagnosis
MH  - Anticoagulants/therapeutic use
MH  - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MH  - Carcinoma, Non-Small-Cell Lung/complications/drug therapy/*genetics
MH  - Female
MH  - Gene Rearrangement/genetics
MH  - Humans
MH  - Lung Neoplasms/diagnostic imaging/*pathology
MH  - Molecular Targeted Therapy/methods
MH  - Mutation
MH  - Neoplasm Staging/methods
MH  - Pleural Effusion, Malignant/diagnosis/metabolism
MH  - Protein-Tyrosine Kinases/*genetics
MH  - Proto-Oncogene Proteins/*genetics
MH  - Pulmonary Embolism/*diagnosis/drug therapy/etiology
MH  - Thoracentesis/instrumentation
MH  - Tomography, X-Ray Computed/methods
MH  - Ultrasonography, Interventional/methods
MH  - Young Adult
EDAT- 2020/09/05 06:00
MHDA- 2021/05/04 06:00
CRDT- 2020/09/05 06:00
PHST- 2020/06/06 00:00 [received]
PHST- 2020/07/01 00:00 [accepted]
PHST- 2020/09/05 06:00 [entrez]
PHST- 2020/09/05 06:00 [pubmed]
PHST- 2021/05/04 06:00 [medline]
AID - 10.4081/monaldi.2020.1435 [doi]
PST - epublish
SO  - Monaldi Arch Chest Dis. 2020 Aug 7;90(3). doi: 10.4081/monaldi.2020.1435.